Nu Skin Enterprises, Inc. (NUS) Cash Flow Statement

The persistent and violent divergence between net income and operating cash flow across the ten-quarter window — including a $533K net loss with $3.3M OCF in 2024Q1 and a $118.3M net loss against $51.2M OCF in 2024Q2 — strongly suggests large non-cash impairments or write-downs repeatedly depress GAAP earnings without corresponding cash impact. Conversely, 2025Q1's $107.5M net income paired with only $389K of operating cash flow likely reflects acquisition-related gains that inflated accounting profit without generating cash. This pattern means reported net income has limited analytical value as a proxy for economic performance, and investors should anchor cash flow valuation on OCF rather than bottom-line results.

The FCF margin trajectory tells a deteriorating story: 9.8% in 2024Q2, 9.3% in 2025Q2, then collapsing to 1.6% by 2026Q2, consistent with the ten-quarter revenue contraction described in prior income statement analysis. Even though capex remains modest, the underlying operating cash engine is weakening faster than cost cuts can offset, suggesting that further revenue erosion could push the company into sustained FCF-negative territory without additional restructuring actions.

The pattern of large positive working capital releases in earlier periods (e.g., $36.0M in 2024Q3) followed by negative swings (e.g., $28.4M use in 2025Q4 and $35.5M in 2026Q1) suggests inconsistent collection dynamics or inventory positioning, which may reflect the operational disruptions accompanying sustained revenue decline. Management should monitor whether the Q2 2026 working capital release represents genuine receivables recovery or merely a timing artifact of reduced purchasing activity. Either way, the volatility reduces the reliability of quarterly OCF as a stable cash benchmark.

This enormous gap — the largest contributors likely being asset impairments, goodwill writedowns, or deferred tax charges — suggests the balance sheet has been progressively marked down to reflect the reality of a structurally shrinking business. While the cash operations remain nominally positive, the scale of non-cash write-downs implies that prior capital investments may not be recoverable at book value, raising questions about the carrying value of remaining assets. Investors should track whether this non-cash charge cycle stabilizes or accelerates as revenue continues to decline.